Latest News & Stories
Seeking the Next Vaccine Visionaries
Each year, we ask the global health community to nominate individuals who have made significant contributions to vaccinology or a complementary field for consideration for our highest scientific honor, the Albert B. Sabin Gold Medal, and our Rising Star Award which recognizes early- to mid-career professionals. Nominate today!
Global Immunization Insights Dashboard
Sabin's dashboard provides a broader view of the factors impacting immunization in order to better understand what is needed to reach 1 billion children with vaccines by the end of the decade.
Q&A: Behind the Marburg Virus Outbreak in Rwanda
Sabin’s rapid delivery of investigational vaccines during Rwanda’s Marburg outbreak showcased exceptional coordination among all the partners. This Q&A unpacks the timeline, Sabin’s role, the clinical trial, the vaccine candidate, and key lessons for future collaborations.
Local Impact, Global Change
Explore how Sabin’s partners drive impact on the ground. Discover their stories here, and check back for updates on new locations and projects.
Confronting Deadly Diseases
Vaccines are our best defense against disease. Yet, we still have lethal diseases that need a vaccine solution urgently. Sabin’s R&D team is tackling two such threats: Sudan ebolavirus and Marburg virus disease. There are no approved vaccines for either of these viruses which have left behind a trail of outbreaks, ending many lives and livelihoods in Africa. Sabin’s vaccines are in Phase 2 clinical trials in Uganda and Kenya.
Making a Case for Vaccines
We make vaccines more accessible, enable innovation and expand immunization across the globe.